Nifedipine versus labetalol in the treatment of hypertensive disorders of pregnancy

Archives of Gynecology and Obstetrics

Volumn 286, Issue 3, 2012, Pages 637-642

  Giannubilo, Stefano R ^a   Bezzeccheri, Valeria ^a   Cecchi, Stefano ^a   Landi, Beatrice ^a   Battistoni, Giovanna I ^a   Vitali, Paola ^a   Cecchi, Lucia ^a   Tranquilli, Andrea L ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Hypertension; Labetalol; Nifedipine; Pregnancy

Indexed keywords

LABETALOL; NIFEDIPINE;

ARTICLE; CONGENITAL MALFORMATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG INDUCED HEADACHE; DYSPNEA; FEMALE; FETUS; FETUS HEART RATE; FETUS OUTCOME; HEARTBURN; HELLP SYNDROME; HUMAN; HUMAN CELL; INFANT; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; NAUSEA; NEWBORN; NEWBORN DISEASE; PREECLAMPSIA; PREGNANCY OUTCOME; RETROSPECTIVE STUDY;

ADRENERGIC BETA-ANTAGONISTS; CALCIUM CHANNEL BLOCKERS; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; LABETALOL; NIFEDIPINE; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 84867998700     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2371-x     Document Type: Article

References (39)

1. Samadi AR, Mayberry RM, Zaidi AA, Pleasant JC, McGhee N Jr, Rice RJ (1996) Maternal hypertension and associated pregnancy complications among African-American and other women in the United States. Obstet Gynecol 87:557-563 (Pubitemid 26102741)
2. Knott C (1991) The treatment of hypertension in pregnancy. Clinical pharmacokinetic considerations. Clin Pharmacokinet 21:233-241
3. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ (2007) Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 24:CD002252
4. Sibai BM (2003) Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102:181-192 (Pubitemid 36792143)
5. Report of the National High Blood Pressure Education Program, Working group report on high blood pressure in pregnancy (2000) Am J Obstet Gynecol 183:S1-S22
6. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J, Peek MJ, Rowan JA, Walters BN, Austalasian Society of the Study of Hypertension in Pregnancy (2000) The detection, investigation and management of hypertension in pregnancy: Executive summary. Aust NZ J Obstet Gynaecol 40:133-138 (Pubitemid 30323583)
7. Rey E, LeLorier J, Burgess E, Lange IR, Leduc L (1997) Report of the Canadian Hypertension Society consensus conference: Pharmacologic treatment of hypertensive disorders in pregnancy. Can Med Assoc J 157:1245-1254
8. Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA (1991) Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol 78:128-135
9. Thorpe-Beeston JG, Armar NA, Dancy M, Cochrane GW, Ryan G, Rodeck CH (1993) Pregnancy and ACE inhibitors. Br J Obstet Gynaecol 100:692-693 (Pubitemid 23209771)
10. Flowers CE, Grizzle JE, Easterling WE, Bonner OB (1962) Chlorthiazide as a prophylaxis against toxemia of pregnancy. Am J Obstet Gynecol 84:919-929
11. Lindheimer MD, Barron WM (2000) Medical disorders in pregnancy. Mosby, St. Louis
12. Smith P, Anthony J, Johanson R (2000) Nifedipine in pregnancy. Br J Obstet Gynaecol 107:299-307 (Pubitemid 30145368)
13. Bortolus R, Ricci E, Chatenoud L, Parazzini F (2000) Nifedipine administered in pregnancy: Effect on the development of children at 18 months. BJOG 107:792-794 (Pubitemid 30311917)
14. Tranquilli AL, Giannubilo SR (2009) Use and safety of calcium channel blockers in obstetrics. Curr Med Chem 16:3330-3340
15. Podymow T, August P (2008) Update on the use of antihypertensive drugs in pregnancy. Hypertension 51:960-969 (Pubitemid 351398945)
16. Briggs GG, Freeman RK, Yae SJ (1994) Drugs in pregnancy and lactation. Williams & Wilkins, Baltimore
17. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM (2001) The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hyper Pregnancy 20:9-14
18. ACOG Committee on Practice Bulletins-Obstetrics (2002) Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 99:159-167
19. Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM (1986) Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 155:501-509 (Pubitemid 16015243)
20. Nicolini U, Ferrazzi E, Molla R, Massa E, Cicognani G, Santarone M, Bellotti M, Pardi G (1986) Accuracy of an average ultrasonic laboratory in measurements of fetal biparietal diameter, head circumference and abdominal circumference. J Perinat Med 14:101-107 (Pubitemid 16050765)
21. Wichman K, Ryden G, Karlberg BE (1984) A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy. Scand J Clin Lab Invest 169:90-94
22. Sandstrom B (1978) Antihypertensive treatment with the adrenergic beta-receptor blocker metoprolol during pregnancy. Gynecol Obstet Invest 9:195-204 (Pubitemid 9141370)
23. Gallery EDM, Ross ME, Gyory AZ (1985) Antihypertensive treatment in pregnancy: Analysis of different responses to oxprenolol and methyldopa. BMJ 291:563-566 (Pubitemid 15225457)
24. Fidler J, Smith V, Fayers P, De Swiet M (1983) Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy. BMJ 286:1927-1930 (Pubitemid 13106255)
25. Plouin PF, Breart G, Llado J, Dalle M, Keller ME, Goujon H, Berchel C (1990) A randomized comparison of early with conservative use of antihypertensive drugs in the management of pregnancyinduced hypertension. Br J Obstet Gynaecol 97:134-141 (Pubitemid 20134283)
26. Sibai BM, Gonzalez AR, Mabie WC, Morettini M (1987) A comparison of labetalol plus hospitalisation versus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol 70:323-327 (Pubitemid 17151649)
27. Magee LA (2000) Fetal growth restriction. Lancet 355:1366-1372
28. Butters L, Kennedy S, Rubin PC (1990) Atenolol in essential hypertension during pregnancy. Br Med J 301:587-589 (Pubitemid 20346537)
29. Lydakis C, Lip GYH, Beevers M, Beevers DG (1999) Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 12:541-547 (Pubitemid 29268384)
30. Lip GY, Beevers M, Churchill D, Shaffer LM, Beevers DG (1997) Effects of atenolol on birth weight. Am J Cardiol 79:1436-1438
31. Easterling TR, Brateng D, Schmucker B, Brown Z, Millard SP (1999) Prevention of preeclampsia: A randomized trial of atenolol in hyperdynamic patients before onset of hypertension. Obstet Gynecol 93:725-733 (Pubitemid 29190671)
32. Cruickshank DJ, Robertson AA, Campbell DM, MacGillivray I (1992) Does labetalol influence the development of proteinuria in pregnancy hypertension? A randomized controlled study. Eur J Obstet Gynecol Reprod Biol 45:47-51
33. Plouin PF, Breart G, Maillard F, Papiernik E, Relier JP (1988) Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: A randomised controlled trial. Br J Obstet Gynaecol 95:868-876
34. Sibai BM, Mabie WC, Shamsa F, Villar MA, Anderson GD (1990) A comparison of no medication vs methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 162:960-967 (Pubitemid 20155414)
35. Pickles CJ, Symonds EM, Pipkin FB (1989) The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension. Br J Obstet Gynaecol 96:38-43 (Pubitemid 19046109)
36. Sibai BM, Grossman RA, Grossman HG (1984) Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol 150:831-835 (Pubitemid 15237763)
37. Campbell DM, MacGillivray I (1975) The effect of a low calorie diet or a thiazide diuretic on the incidence of pre-eclampsia and on birthweight. Br J Obstet Gynecol 82:572-577
38. Easterling TR, Carr DB, Brateng D, Diederichs C, Schmucker B (2001) Obstet Gynecol 98:427-433
39. Magee LA, Schick B, Donnenfeld AE, Sage SR, Conover B, Cook L, McElhatton PR, Schmidt MA, Koren G (1996) The safety of calcium channel blockers in human pregnancy: A prospective, multicenter cohort study. Am J Obstet Gynecol 174:823-828 (Pubitemid 26111652)